CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

UBS Upgrades Ionis Pharmaceuticals to Buy From Neutral, Adjusts Price Target to $88 From $46

Positive
AI Analysis

Summary

UBS upgraded Ionis Pharmaceuticals to Buy from Neutral and raised its price target to $88 from $46.

Outcome Details

UBS upgraded Ionis to Buy from Neutral and raised its price target to $88 from $46.

Importance:5/10
Sentiment:
0.70
analyst_upgradeprice_targetUBS
Related Companies

Read the original article

Published by yahoo_finance on October 15, 2026 2:33 PM

Read Original